ArticleMolecular carcinogenesis2022

Monocarboxylate transporter 1 is a novel target for breast cancer stem like-cell inhibition by diallyl trisulfide.

Su-Hyeong Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.